Total Funding
37
71
Total FundingSeed raised
Growth Score 37 in past quarter
-1 pts
Heat Score 71 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
25322
Leiters is a pharmaceuticals company that offers compounding medication services.
Acquired by 

Welsh Carson Anderson & Stowe
- Tom Flynn: DirectorPast Role: Good Start Genetics, Director
- Robin Smith Hoke: Co-founder & CEO
About the Company
Leiters is a FDA-registered 503B outsourcing provider of high quality ophthalmology and hospital-based services. We are committed to providing healthcare professionals and their patients with high quality medications. Their team of experts in sterile pharmaceutical manufacturing, repackaging, and compounding provide a sophisticated understanding of
what it takes to elevate quality and consistency of supply in outsourcing. They combine their team of experts, their robust processes and their state of the art manufacturing facilities to ensure the highest quality products and services. They believe the most important consumer of their products are patients, and patients have trusted Leiters with their health for nearly a century.
Women Founded
Women Led
